ADS-ADEA 2015*
Chairs: Jane Holmes-Walker & Jennifer Conn
A combination of 15 SNPs and clinical features in relatives with islet autoantibodies improves prediction of Type 1 Diabetes: implications for prevention trials. (#43)
11:00 AM
A Feasibility Study of a Novel Redundant Electrochemical Sensor for Continuous Glucose Monitoring in Patients With Type 1 Diabetes (Tid) (#44)
11:15 AM
The Performance of an Orthogonally Redundant Glucose Sensor compared to a Simply Redundant Electrochemical Glucose Sensor in Adults with Type 1 Diabetes (#45)
11:30 AM
LY2963016 Insulin Glargine (LY IGlar) Compared with Lantus® Insulin Glargine (IGlar) in Patients with Type 1 Diabetes Mellitus (T1DM): Efficacy, Safety, and Patient-reported Outcomes from the ELEMENT-1 Study (#46)
11:45 AM
Metabolic syndrome in type 1 diabetes: exploring the prevalence of ‘double diabetes’ and the risk of diabetes complications in the Australian National Diabetes Information Audit and Benchmarking (ANDIAB) Initiative (#47)
12:00 PM
Mortality in Type 1 Diabetes is Increased in the Presence of the Metabolic Syndrome, but Remains Lower than in Young Onset Type 2 Diabetes (#48)
12:15 PM
Diabetic Ketoacidosis in Adult Patients – An audit of factors influencing time to normalisation of metabolic parameters. (#49)
12:30 PM
Creatinine is Falsely Elevated in Diabetic Ketoacidosis Patients: A Comparison of 4 Jaffe Assays with an Enzymatic Method. (#50)
12:45 PM